The strong association between GLP-1R gene polymorphisms and the hypoglycemic effects of DPP-4 inhibitors and GLP-1RAs makes the GLP-1R gene a candidate gene for precision medicine in diabetes [56]. This evidence concerns the gene DPP4 and diabetes mellitus.